Status:

COMPLETED

Treatment of Suicidal Women With Borderline Personality Disorder

Lead Sponsor:

University of Washington

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Borderline Personality Disorder

Suicide

Eligibility:

FEMALE

18-60 years

Phase:

PHASE2

Brief Summary

This study is a component analysis of dialectical behavior therapy (DBT) to determine the importance of DBT skills training and DBT individual therapy in treating suicidal women with borderline person...

Detailed Description

People with borderline personality disorder have limited behavioral skills and react abnormally to emotional stimulation. Standard dialectical behavior therapy (SDBT) has been shown to be an effective...

Eligibility Criteria

Inclusion

  • Diagnosis of BPD
  • At least one suicide attempt in the year prior to study entry AND at least one intentional self-injury within the 8 weeks prior to study entry
  • Willing and able to comply with all study requirements

Exclusion

  • IQ less than 70
  • Life-threatening anorexia
  • Street homelessness with no contact information
  • Admittance to a hospital with no expectation of discharge within 3 weeks prior to study entry OR sentenced to a jail or prison term that will last for more than 3 weeks
  • Ordered by the court to receive psychological treatment
  • Meet DSM-IV criteria for schizophrenia, bipolar disorder, or seizure disorder
  • Medical conditions other than BPD that may interfere with the study

Key Trial Info

Start Date :

April 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

99 Patients enrolled

Trial Details

Trial ID

NCT00183651

Start Date

April 1 2004

End Date

June 1 2010

Last Update

February 2 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Washington, Department of Psychology, Behavior Research and Therapy Clinics

Seattle, Washington, United States, 98195-1525